MedTrace Logo

The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke

NCT07167550 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 184

Last updated 2025-09-11

No results posted yet for this study

Summary

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Dimephosphon® in acute ischemic stroke

Conditions

Interventions

DRUG

Dimephosphon®

1 g/ml, concentrate for solution for intravenous infusion

DRUG

Placebo

Placebo IV solution

Sponsors & Collaborators

  • Tatchempharmpreparaty, JSC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-06
Primary Completion
2026-01-31
Completion
2026-04-30

Countries

  • Russia

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07167550 on ClinicalTrials.gov